BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15504399)

  • 1. Anti-termination by SIV Tat requires flexibility of the nascent TAR structure.
    Sommer P; Vartanian JP; Wachsmuth M; Henry M; Guetard D; Wain-Hobson S
    J Mol Biol; 2004 Nov; 344(1):11-28. PubMed ID: 15504399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA recognition and regulation of HIV-1 gene expression by viral factor Tat.
    Naryshkin NA; Gait MJ; Ivanovskaya MG
    Biochemistry (Mosc); 1998 May; 63(5):489-503. PubMed ID: 9632883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HIV-1 replication in viral mutants with altered TAR RNA stem structures.
    Rounseville MP; Lin HC; Agbottah E; Shukla RR; Rabson AB; Kumar A
    Virology; 1996 Feb; 216(2):411-7. PubMed ID: 8607271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
    Fong SE; Greenwood JD; Williamson JC; Derse D; Pallansch LA; Copeland T; Rasmussen L; Mentzer A; Nagashima K; Tobin G; Gonda MA
    Virology; 1997 Jul; 233(2):339-57. PubMed ID: 9217057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
    Kundu M; Ansari SA; Chepenik LG; Pomerantz RJ; Khalili K; Rappaport J; Amini S
    J Hum Virol; 1999; 2(2):72-80. PubMed ID: 10225209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HIV-1 in CEM cells by a potent TAR decoy.
    Lee SW; Gallardo HF; Gaspar O; Smith C; Gilboa E
    Gene Ther; 1995 Aug; 2(6):377-84. PubMed ID: 7584112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TAR hairpin of human immunodeficiency virus type 1 can be deleted when not required for Tat-mediated activation of transcription.
    Das AT; Harwig A; Vrolijk MM; Berkhout B
    J Virol; 2007 Jul; 81(14):7742-8. PubMed ID: 17494072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the position of TAR on transcriptional activation by HIV-1 Tat in vivo.
    Wright S; Luccarini C
    J Mol Biol; 1996 Oct; 263(1):1-7. PubMed ID: 8890908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between Tat of HIV-2 and transcription factor Sp1.
    Pagtakhan AS; Tong-Starksen SE
    Virology; 1997 Nov; 238(2):221-30. PubMed ID: 9400595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transactivation is a conserved function among primate lentivirus Vpr proteins but is not shared by Vpx.
    Philippon V; Matsuda Z; Essex M
    J Hum Virol; 1999; 2(3):167-74. PubMed ID: 10413368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA conformation in the Tat-TAR complex determined by site-specific photo-cross-linking.
    Wang Z; Rana TM
    Biochemistry; 1996 May; 35(20):6491-9. PubMed ID: 8639596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orientation and affinity of HIV-1 Tat fragments in Tat-TAR complex determined by fluorescence resonance energy transfer.
    Cao H; Tamilarasu N; Rana TM
    Bioconjug Chem; 2006; 17(2):352-8. PubMed ID: 16536465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of the complex trans-activating response element RNA structure in simian immunodeficiency virus.
    Centlivre M; Klaver B; Berkhout B; Das AT
    J Virol; 2008 Sep; 82(18):9171-8. PubMed ID: 18596090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement of the human immunodeficiency virus type 1 env gene sequence for TAR-independent trans activation by Tat from the major immediate-early promoter of murine cytomegalovirus.
    Kim YS
    Biochem Biophys Res Commun; 1994 Sep; 203(2):1152-9. PubMed ID: 8093034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altering the context of an RNA bulge switches the binding specificities of two viral Tat proteins.
    Smith CA; Crotty S; Harada Y; Frankel AD
    Biochemistry; 1998 Jul; 37(30):10808-14. PubMed ID: 9692971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication.
    Verhoef K; Koper M; Berkhout B
    Virology; 1997 Oct; 237(2):228-36. PubMed ID: 9356335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of nuclease resistant circular RNA decoys for HIV-Tat and HIV-Rev by autocatalytic splicing.
    Puttaraju M; Been MD
    Nucleic Acids Symp Ser; 1995; (33):152-5. PubMed ID: 8643355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based design of a dimeric RNA-peptide complex.
    Campisi DM; Calabro V; Frankel AD
    EMBO J; 2001 Jan; 20(1-2):178-86. PubMed ID: 11226168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proximity of a Tat peptide to the HIV-1 TAR RNA loop region determined by site-specific photo-cross-linking.
    Wang Z; Huq I; Rana TM
    Bioconjug Chem; 1999; 10(3):512-9. PubMed ID: 10346885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide models of the Tat-TAR protein-RNA interaction.
    Frankel AD
    Protein Sci; 1992 Dec; 1(12):1539-42. PubMed ID: 1304886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.